Literature DB >> 8611653

Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria.

B Lubec1, S Fang-Kircher, T Lubec, H J Blom, G H Boers.   

Abstract

Osteoporosis occurs commonly in homocystinuria. The underlying pathobiochemical mechanism remains unclear; disturbed cross-linking of collagen has been suggested but this hypothesis has not been fully tested, nor have studies on collagen synthesis been performed. We therefore used recently available noninvasive tests for collagen synthesis and cross-linking to examine 10 patients with homocystinuria. Synthesis of collagen type I and type III was not different from age-matched healthy controls as reflected by comparable plasma levels of carboxyterminal propeptide of type I procollagen (PICP) and of plasma levels of N-terminal propeptide of procollagen type III (PIIINP). Collagen type I cross-links expressed by serum carboxyterminal telopeptide of collagen type I (ICTP) were 1.14 +/- 0.24 micrograms/l in the patient group versus 3.29 +/- 0.32 micrograms/l in the control group. This significant reduction of cross-links in the group with homocystinuria did not correlate with serum homocysteine or homocysteic acid concentrations. Our data clearly indicate that the disturbed cross-linking hypothesis still holds and that the bone manifestations of homocystinuria are not due to deficient collagen synthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611653     DOI: 10.1016/0925-4439(95)00119-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  46 in total

1.  Multifocal bursitis in a patient with homozygous homocystinuria.

Authors:  C Haedecke; A J Anders; H Kellner; N Weiss
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

2.  Osteoporosis in late-diagnosed adult homocystinuric patients.

Authors:  F Parrot; I Redonnet-Vernhet; D Lacombe; H Gin
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

3.  The genetics of response to estrogen treatment.

Authors:  Bente L Langdahl
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

Review 4.  B vitamins, homocysteine, and bone disease: epidemiology and pathophysiology.

Authors:  Robert R McLean; Marian T Hannan
Journal:  Curr Osteoporos Rep       Date:  2007-09       Impact factor: 5.096

5.  The relation of plasma homocysteine to radiographic knee osteoarthritis.

Authors:  M Fayfman; J Niu; Y Q Zhang; D T Felson; B Sack; P Aliabadi; J Selhub; D J Hunter
Journal:  Osteoarthritis Cartilage       Date:  2008-11-30       Impact factor: 6.576

6.  Association of Methylene Tetrahydrofolate Reductase Polymorphism with BMD and Homocysteine in Premenopausal North Indian Women.

Authors:  Sanjeev Kumar Pandey; Ankur Singh; Sunil Kumar Polipalli; Sangeeta Gupta; Seema Kapoor
Journal:  J Clin Diagn Res       Date:  2013-12-15

7.  Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.

Authors:  Rui Bai; Wanlin Liu; Aiqing Zhao; Zhenqun Zhao; Dianming Jiang
Journal:  Mol Biol Rep       Date:  2012-12-11       Impact factor: 2.316

8.  Strontium ranelate decreases plasma homocysteine levels in postmenopausal osteoporotic women.

Authors:  Ilhan Bayhan; Dilek Uygur; Nil Ugurlu; Gulnur Ozaksit
Journal:  Rheumatol Int       Date:  2008-09-26       Impact factor: 2.631

Review 9.  Mitochondrial epigenetics in bone remodeling during hyperhomocysteinemia.

Authors:  Anuradha Kalani; Pradip K Kamat; Michael J Voor; Suresh C Tyagi; Neetu Tyagi
Journal:  Mol Cell Biochem       Date:  2014-06-18       Impact factor: 3.396

Review 10.  Regulation of gene expression by 1,25-dihydroxyvitamin D3 in bone cells: exploiting new approaches and defining new mechanisms.

Authors:  J Wesley Pike; Seong Min Lee; Mark B Meyer
Journal:  Bonekey Rep       Date:  2014-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.